Buell Jennifer (CIK 1711184) reported 14 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-01-14). Recent activity: Sell INKT (10,024 shares), Buy INKT (31,474 shares), Sell INKT (5,351 shares), Buy INKT (18,229 shares), Buy AGEN (581 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-14 | MiNK Therapeutics, Inc. (INKT) | Chief Executive Officer | Sell | 10,024 | $111,467 |
| 2026-01-06 | MiNK Therapeutics, Inc. (INKT) | Chief Executive Officer | Buy | 31,474 | $349,991 |
| 2025-10-03 | MiNK Therapeutics, Inc. (INKT) | Chief Executive Officer | Sell | 5,351 | $82,191 |
| 2025-09-11 | MiNK Therapeutics, Inc. (INKT) | Chief Executive Officer | Buy | 18,229 | $279,997 |
| 2025-05-06 | AGENUS INC (AGEN) | Director | Buy | 581 | $1,807 |
| 2025-05-05 | AGENUS INC (AGEN) | Director | Buy | 869 | $1,808 |
| 2025-04-10 | AGENUS INC (AGEN) | Director | Buy | 1,159 | $1,808 |
| 2025-03-27 | AGENUS INC (AGEN) | Director | Buy | 1,123 | $1,808 |
| 2025-03-24 | AGENUS INC (AGEN) | Director | Buy | 409 | $961 |
| 2025-03-11 | AGENUS INC (AGEN) | Director | Buy | 545 | $1,809 |
| 2025-03-05 | AGENUS INC (AGEN) | Director | Buy | 626 | $2,078 |
| 2025-02-18 | AGENUS INC (AGEN) | Director | Buy | 516 | $1,806 |
| 2025-02-04 | AGENUS INC (AGEN) | Director | Sell | 270 | $964 |
| 2025-01-28 | AGENUS INC (AGEN) | Director | Buy | 776 | $2,770 |
Source: SEC Form 4 filings · as of 2026-01-14